ActiGraph activity monitors and a mobile app from Clinical Ink are are at the heart of a newly announced pilot study backed by Bayer, according to a statement released today by ActiGraph. The ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback